Cargando…

Imaging of cerebrovascular pathology in animal models of Alzheimer's disease

In Alzheimer's disease (AD), vascular pathology may interact with neurodegeneration and thus aggravate cognitive decline. As the relationship between these two processes is poorly understood, research has been increasingly focused on understanding the link between cerebrovascular alterations an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Klohs, Jan, Rudin, Markus, Shimshek, Derya R., Beckmann, Nicolau
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2014
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3952109/ https://www.ncbi.nlm.nih.gov/pubmed/24659966 http://dx.doi.org/10.3389/fnagi.2014.00032

Ejemplares similares

Cortical hypoperfusion and reduced cerebral metabolic rate of oxygen in the arcAβ mouse model of Alzheimer’s disease
por: Ni, Ruiqing, et al.
Publicado: (2018)

fMRI Reveals Mitigation of Cerebrovascular Dysfunction by Bradykinin Receptors 1 and 2 Inhibitor Noscapine in a Mouse Model of Cerebral Amyloidosis
por: Ni, Ruiqing, et al.
Publicado: (2019)

Extracerebral Tissue Damage in the Intraluminal Filament Mouse Model of Middle Cerebral Artery Occlusion
por: Vaas, Markus, et al.
Publicado: (2017)

Magnetic Resonance Q Mapping Reveals a Decrease in Microvessel Density in the arcAβ Mouse Model of Cerebral Amyloidosis
por: Ielacqua, Giovanna D., et al.
Publicado: (2016)

PET Imaging in Animal Models of Alzheimer’s Disease
por: Chen, Baosheng, et al.
Publicado: (2022)

APOE and Alzheimer’s Disease: Neuroimaging of Metabolic and Cerebrovascular Dysfunction
por: Brandon, Jason A., et al.
Publicado: (2018)

Cortical cerebrovascular and metabolic perturbations in the 5xFAD mouse model of Alzheimer’s disease
por: Jullienne, Amandine, et al.
Publicado: (2023)

Cerebrovascular pathology in Down syndrome and Alzheimer disease
por: Head, Elizabeth, et al.
Publicado: (2017)

Cerebrovascular-Reactivity Mapping Using MRI: Considerations for Alzheimer’s Disease
por: Chen, J. J.
Publicado: (2018)

Cerebrovascular disease promotes tau pathology in Alzheimer’s disease
por: Laing, Krystal K, et al.
Publicado: (2020)

Evaluation of cannabinoid type 2 receptor expression and pyridine-based radiotracers in brains from a mouse model of Alzheimer’s disease
por: Kecheliev, Vasil, et al.
Publicado: (2022)

Cerebrovascular Senescence Is Associated With Tau Pathology in Alzheimer's Disease
por: Bryant, Annie G., et al.
Publicado: (2020)

Genetic models of cleavage-reduced and soluble TREM2 reveal distinct effects on myelination and microglia function in the cuprizone model
por: Beckmann, Nicolau, et al.
Publicado: (2023)

PET Imaging of Tau Pathology in Alzheimer’s Disease and Tauopathies
por: James, Olga G., et al.
Publicado: (2015)

Iron and Alzheimer’s Disease: From Pathology to Imaging
por: Tran, Dean, et al.
Publicado: (2022)

An Automated Open-Source Workflow for Standards-Compliant Integration of Small Animal Magnetic Resonance Imaging Data
por: Ioanas, Horea-Ioan, et al.
Publicado: (2020)

Resting State BOLD Variability in Alzheimer’s Disease: A Marker of Cognitive Decline or Cerebrovascular Status?
por: Scarapicchia, Vanessa, et al.
Publicado: (2018)

Early detection of cerebrovascular pathology and protective antiviral immunity by MRI
por: Liu, Li, et al.
Publicado: (2022)

The role of ADAM17 in cerebrovascular and cognitive function in the APP/PS1 mouse model of Alzheimer’s disease
por: Tian, Yanna, et al.
Publicado: (2023)

Ceramide in cerebrovascular diseases
por: Yuan, Huiqi, et al.
Publicado: (2023)

Predicting Cerebral Amyloid Angiopathy-Related Intracerebral Hemorrhages and Other Cerebrovascular Disorders in Alzheimer’s Disease
por: Yamada, Masahito
Publicado: (2012)

The Nuclear Receptor PPARγ as a Therapeutic Target for Cerebrovascular and Brain Dysfunction in Alzheimer's Disease
por: Nicolakakis, Nektaria, et al.
Publicado: (2010)

Cerebrovascular Pathology in Hypertriglyceridemic APOB-100 Transgenic Mice
por: Hoyk, Zsófia, et al.
Publicado: (2018)

Current Animal Models of Alzheimer’s Disease: Challenges in Translational Research
por: Cuadrado-Tejedor, Mar, et al.
Publicado: (2014)

Cerebrovascular Resistance: The Basis of Cerebrovascular Reactivity
por: Duffin, James, et al.
Publicado: (2018)

Microglial autophagy in cerebrovascular diseases
por: Chen, Man, et al.
Publicado: (2022)

Non-invasive near-infrared fluorescence imaging of the neutrophil response in a mouse model of transient cerebral ischaemia
por: Vaas, Markus, et al.
Publicado: (2016)

Fiberoptic hemodynamic spectroscopy reveals abnormal cerebrovascular reactivity in a freely moving mouse model of Alzheimer’s disease
por: Gareau, Daniel S., et al.
Publicado: (2023)

Aged Cattle Brain Displays Alzheimer's Disease-Like Pathology and Promotes Brain Amyloidosis in a Transgenic Animal Model
por: Moreno-Gonzalez, Ines, et al.
Publicado: (2022)

Longitudinal Assessment of Amyloid Pathology in Transgenic ArcAβ Mice Using Multi-Parametric Magnetic Resonance Imaging
por: Klohs, Jan, et al.
Publicado: (2013)

Editorial: Cerebrovascular imaging—From micro- to macroscopic scales
por: Zhu, Chengcheng, et al.
Publicado: (2022)

Animal model of assessing cerebrovascular functional reserve by imaging photoplethysmography
por: Mamontov, Oleg V., et al.
Publicado: (2020)

Pioglitazone Improves Reversal Learning and Exerts Mixed Cerebrovascular Effects in a Mouse Model of Alzheimer’s Disease with Combined Amyloid-β and Cerebrovascular Pathology
por: Papadopoulos, Panayiota, et al.
Publicado: (2013)

Association of cerebrovascular dysfunction with the development of Alzheimer’s disease-like pathology in OXYS rats
por: Stefanova, Natalia A., et al.
Publicado: (2018)

Gender differences in white matter pathology and mitochondrial dysfunction in Alzheimer’s disease with cerebrovascular disease
por: Gallart-Palau, Xavier, et al.
Publicado: (2016)

Application of transcranial Doppler in cerebrovascular diseases
por: Wan, Yuxiao, et al.
Publicado: (2022)

Prostacyclin Promotes Degenerative Pathology in a Model of Alzheimer’s Disease
por: Womack, Tasha R., et al.
Publicado: (2022)

The Role of Copper in Tau-Related Pathology in Alzheimer’s Disease
por: Zubčić, Klara, et al.
Publicado: (2020)

Neuroprotective effects of resveratrol in Alzheimer disease pathology
por: Rege, Shraddha D., et al.
Publicado: (2014)

Alzheimer's Disease: Tau Pathology and Dysfunction of Endocytosis
por: Ando, Kunie, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1976u3nfjurnnhkj0o1tm5d0cg